Groupe Tete Pharmaceutical SRL
Groupe Tete Pharmaceutical reported total assets of €1.15m at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Aug 2026).
By total assets for 2025, Groupe Tete Pharmaceutical ranks among the 100 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Groupe Tete Pharmaceutical shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +54 % Total assets +17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Groupe Tete Pharmaceutical's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Aug 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 01 Jul 2023
- Year ended 31 Dec 2021filed on 01 Sep 2022
Groupe Tete Pharmaceutical's financial analysis
- Solvency44.9%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Groupe Tete Pharmaceutical
Groupe Tete Pharmaceutical's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0542.600.182
- VAT number
- BE0542600182
- Peppol
- Registered · 0208:0542600182 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Nov 2013
- Registered office
- 1400 Nivelles
- Latest accounts
- 2025 · filed on 05 Aug 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Groupe Tete Pharmaceutical (SRL) has been based in Nivelles since 2013, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 62,922 € and equity of 517,943 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Groupe Tete Pharmaceutical
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Givry Manufacture of basic pharmaceutical products Quévy · balance sheet €1.30m
- Niali Retail sale of pharmaceutical products Mechelen · balance sheet €1.41m
- MAHO Retail sale of pharmaceutical products Tienen · balance sheet €1.00m
- JM Pharma Care Retail sale of pharmaceutical products Andenne · balance sheet 878,696 €
- Apotheek Hooijmaaijer BV Retail sale of pharmaceutical products Sint-Katelijne-Waver · balance sheet €1.13m
- Sobegapharma Manufacture of basic pharmaceutical products Mons · balance sheet €1.04m
- K-Farma Retail sale of pharmaceutical products Zandhoven · balance sheet €1.94m
- Markri-Farma Retail sale of pharmaceutical products Herent · balance sheet €2.60m
Frequently asked questions about Groupe Tete Pharmaceutical
What is the revenue of Groupe Tete Pharmaceutical?
Groupe Tete Pharmaceutical files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Groupe Tete Pharmaceutical?
In Belgium, the VAT number is the company number prefixed with BE: BE0542600182 for Groupe Tete Pharmaceutical, if the company is VAT-registered. Its company number (CBE) is 0542.600.182.
Where is the registered office of Groupe Tete Pharmaceutical?
According to the CBE register, the registered office of Groupe Tete Pharmaceutical is in 1400 Nivelles.
What is the equity of Groupe Tete Pharmaceutical?
At the close of the 2025 financial year, the equity of Groupe Tete Pharmaceutical amounts to 517,943 €, a solvency of 44.9% of total assets.
Who manages Groupe Tete Pharmaceutical?
The register lists 1 active mandates at Groupe Tete Pharmaceutical. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Groupe Tete Pharmaceutical within its sector?
By total assets for 2025, Groupe Tete Pharmaceutical ranks among the 100 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year.
The full file of Groupe Tete Pharmaceutical
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →